239 related articles for article (PubMed ID: 37439336)
21. Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries.
Lundin C; Forestier E; Klarskov Andersen M; Autio K; Barbany G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B; ; ;
J Hematol Oncol; 2014 Apr; 7():32. PubMed ID: 24726034
[TBL] [Abstract][Full Text] [Related]
22. Evolution of myeloid leukemia in children with Down syndrome.
Saida S
Int J Hematol; 2016 Apr; 103(4):365-72. PubMed ID: 26910243
[TBL] [Abstract][Full Text] [Related]
23. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia.
Kearney L; Gonzalez De Castro D; Yeung J; Procter J; Horsley SW; Eguchi-Ishimae M; Bateman CM; Anderson K; Chaplin T; Young BD; Harrison CJ; Kempski H; So CW; Ford AM; Greaves M
Blood; 2009 Jan; 113(3):646-8. PubMed ID: 18927438
[TBL] [Abstract][Full Text] [Related]
24. The paradox of Myeloid Leukemia associated with Down syndrome.
Gupte A; Al-Antary ET; Edwards H; Ravindranath Y; Ge Y; Taub JW
Biochem Pharmacol; 2022 Jul; 201():115046. PubMed ID: 35483417
[TBL] [Abstract][Full Text] [Related]
25. Duplication and loss of chromosome 21 in two children with Down syndrome and acute leukemia.
Rogan PK; Close P; Blouin JL; Seip JR; Gannutz L; Ladda RL; Antonarakis SE
Am J Med Genet; 1995 Nov; 59(2):174-81. PubMed ID: 8588582
[TBL] [Abstract][Full Text] [Related]
26. Acute leukemias in children with Down syndrome.
Seewald L; Taub JW; Maloney KW; McCabe ER
Mol Genet Metab; 2012 Sep; 107(1-2):25-30. PubMed ID: 22867885
[TBL] [Abstract][Full Text] [Related]
27. The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome.
Lanza C; Volpe G; Basso G; Gottardi E; Perfetto F; Cilli V; Spinelli M; Ricotti E; Guerrasio A; Madon E; Saglio G
Leukemia; 1997 Jun; 11(6):820-1. PubMed ID: 9177434
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q.
Cavani S; Perfumo C; Argusti A; Pierluigi M; Perroni L; Schmiegelow K; Petersen MB; Cotter FE; Strigini P; Dagna-Bricarelli F; Nizetić D
Br J Haematol; 1998 Oct; 103(1):213-6. PubMed ID: 9792310
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.
Hefti E; Blanco JG
J Pediatr Hematol Oncol; 2016 May; 38(4):283-7. PubMed ID: 26907658
[TBL] [Abstract][Full Text] [Related]
30. Unique clinical and biological features of leukemia in Down syndrome children.
Xavier AC; Ge Y; Taub J
Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
[TBL] [Abstract][Full Text] [Related]
31. Leukemogenesis in infants and young children with trisomy 21.
Roberts I
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):1-8. PubMed ID: 36485097
[TBL] [Abstract][Full Text] [Related]
32. Philadelphia chromosome-positive acute lymphoblastic leukemia and Down syndrome.
Tamaura M; Iwasaki F; Yokosuka T; Fukuda K; Hamonoue S; Goto H
Pediatr Int; 2016 Aug; 58(8):794-7. PubMed ID: 27325175
[TBL] [Abstract][Full Text] [Related]
33. Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602).
Watson MS; Carroll AJ; Shuster JJ; Steuber CP; Borowitz MJ; Behm FG; Pullen DJ; Land VJ
Blood; 1993 Nov; 82(10):3098-102. PubMed ID: 8219201
[TBL] [Abstract][Full Text] [Related]
34. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
[TBL] [Abstract][Full Text] [Related]
35. Lineage conversion from acute lymphoblastic leukemia to acute myeloid leukemia on rearrangement of the IgH gene in a patient with Down syndrome.
Tsuboi K; Yazaki M; Miwa H; Iida S; Banno S; Wakita A; Nitta M; Ueda R
Int J Hematol; 2002 Jul; 76(1):69-73. PubMed ID: 12138899
[TBL] [Abstract][Full Text] [Related]
36. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
Lundin C; Hjorth L; Behrendtz M; Nordgren A; Palmqvist L; Andersen MK; Biloglav A; Forestier E; Paulsson K; Johansson B
Genes Chromosomes Cancer; 2012 Feb; 51(2):196-206. PubMed ID: 22072402
[TBL] [Abstract][Full Text] [Related]
37. Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations.
Litz CE; Davies S; Brunning RD; Kueck B; Parkin JL; Gajl Peczalska K; Arthur DC
Leukemia; 1995 Sep; 9(9):1432-9. PubMed ID: 7658708
[TBL] [Abstract][Full Text] [Related]
38. Relationship of chromosome 21 and acute leukemia in children with Down syndrome.
Taub JW
J Pediatr Hematol Oncol; 2001; 23(3):175-8. PubMed ID: 11305722
[No Abstract] [Full Text] [Related]
39. The acute lymphoblastic leukemia of Down Syndrome - Genetics and pathogenesis.
Izraeli S
Eur J Med Genet; 2016 Mar; 59(3):158-61. PubMed ID: 26631987
[TBL] [Abstract][Full Text] [Related]
40. Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML(M7).
Ives JH; Dagna-Bricarelli F; Basso G; Antonarakis SE; Jee R; Cotter F; Nizetić D
Genes Chromosomes Cancer; 1998 Sep; 23(1):61-6. PubMed ID: 9713998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
